Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males
Phase 1
Terminated
- Conditions
- HypogonadismHypogonadism, MaleGonadal DisordersEndocrine System DiseasesTestosterone Deficiency
- Interventions
- First Posted Date
- 2017-11-07
- Last Posted Date
- 2019-05-16
- Lead Sponsor
- TesoRx Pharma, LLC
- Target Recruit Count
- 9
- Registration Number
- NCT03335254
- Locations
- 🇺🇸
California Clinical Trials, Glendale, California, United States
Oral Testosterone for the Treatment of Hypogonadism in Males
- First Posted Date
- 2014-08-21
- Last Posted Date
- 2016-05-30
- Lead Sponsor
- TesoRx Pharma, LLC
- Target Recruit Count
- 25
- Registration Number
- NCT02222558
- Locations
- 🇺🇸
San Diego Sexual Medicine, San Diego, California, United States
Oral Testosterone for the Treatment of Hypogonadism
- First Posted Date
- 2012-10-30
- Last Posted Date
- 2015-12-15
- Lead Sponsor
- TesoRx Pharma, LLC
- Target Recruit Count
- 130
- Registration Number
- NCT01717768
- Locations
- 🇺🇸
Urology Group of Southern California, Los Angeles, California, United States
News
No news found